Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 billion deal

Thermo Fisher Scientific Inc has agreed to buy German genetic testing company Qiagen in a $11.5 billion deal as the U.S.-based group looks to bolster its health diagnostic business.